Collectively, the increase in active Src (pSrc Y416), EGFR and AnxA2 upon Herceptin therapy and decrease in phosphorylation of Src and EGFR suggests that the cancer cells reprogram themselves by upregulation of a group of proteins which work together to overcome any stress such as Herceptin therapy. Here, ANXA2 is linked to cancer.